Cell line · CVCL_2529

Ishikawa

Cancer cell line, Homo sapiens. Type I endometrial adenocarcinoma. 61 papers.

4 sourcescell-lines-2026-11-14-0.1.0

Cite this record

ConductScience Library. Ishikawa. Cell lines, record CVCL_2529. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_2529

On this page

Cell line

As Cellosaurus gives it.

Name: Ishikawa
Accession: CVCL_2529
RRID: RRID:CVCL_2529
Synonyms: ISHIKAWA, ISHI
Species: Homo sapiens (Human)
Sex: Female
Age at sampling: 39Y
Category: Cancer cell line
Diseases: Type I endometrial adenocarcinoma (NCIt C40145)
Derived from: Endometrium (in situ)
Entry created: 2012-04-04
Entry updated: 2026-10-22

Source Cellosaurus

Problems0

Cellosaurus records no problem for this cell line.

None in this release.

Papers61

Paper	Journal	Year	How we know	Source
Fluoxetine Is Associated with Reduced Cell Viability and Decreased pERK1/2 Immunoreactivity in Ishikawa Endometrial Cancer Cells In Vitro: An Exploratory Study.	Life (Basel)	2026	Its Methods give the RRID and name the line	PubMed
Agmatine Sulfate Is Associated with Altered Redox Status, Apoptosis-Associated Responses, and AKT/JNK Signalling in Ishikawa Endometrial Cancer Cells.	Life (Basel)	2026	Its Methods give the RRID and name the line	PubMed
Integration of Spatial Transcriptomics and Mendelian Randomization Identifies Candidate Molecular Regulators of Endometrial Cancer Progression.	Cells	2026	Its Methods give the RRID and name the line	PubMed
p190A/ARHGAP35 and p190B/ARHGAP5 proteins in endometrial cancer: a novel cancer-relevant paralog interplay.	Mol Oncol	2026	Its Methods give the RRID and name the line	PubMed
Lithium Chloride-Induced Nuclear Envelope Remodeling in 3D Endometrial Cancer Spheroids.	Int J Mol Sci	2026	Its Methods give the RRID and name the line	PubMed
Targeting Steroid-Metabolizing Enzymes with 15β-Substituted Estrone Analogues: Dual Discovery of AKR1C2/17β-HSD1 Inhibitors and a Fluorescent 17β-HSD1 Ligand.	Cancers (Basel)	2026	Its Methods give the RRID and name the line	PubMed
Large-Scale Quantitative Morphometry of Platelet α-Granules via SIM Super-Resolution Microscopy for Cancer Liquid Biopsy.	Adv Sci (Weinh)	2026	Its Methods give the RRID and name the line	PubMed
Mitochondrial Injury Accompanied by Intermediate Filament Remodeling Following Lithium Chloride Exposure in 3D Endometrial Cancer Spheroids.	Biomedicines	2026	Its Methods give the RRID and name the line	PubMed
DHX9 Inhibition Enhances Paclitaxel Sensitivity by Inducing Mitotic Failure in Ovarian and Endometrial Cancers.	Mol Cancer Ther	2026	Its Methods give the RRID and name the line	PubMed
Multifaceted role of POU5F1P1 in regulating its parental stem cell gene, POU5F1.	iScience	2026	Its Methods give the RRID and name the line	PubMed

1 to 10 of 61

See all 61 papers

Relatives31

Relation	Cell line	Accession	Source
Derived from it	EDITGENE Ishikawa-Cas9	CVCL_F5PN	Cell lines
Derived from it	EDITGENE Ishikawa-CopGFP	CVCL_F6AK	Cell lines
Derived from it	EDITGENE Ishikawa-FLUC	CVCL_F5SY	Cell lines
Derived from it	EDITGENE MAPK7 (p.D200A) Point Mutation in Ishikawa Cell Line	CVCL_F5YI	Cell lines
Derived from it	EIIL	CVCL_W441	Cell lines
Derived from it	HyCyte Ishikawa KO-hCTNNBIP1	CVCL_F1R3	Cell lines
Derived from it	IK-6	CVCL_N296	Cell lines
Derived from it	IK-90	CVCL_9996	Cell lines
Derived from it	ISH/DDP	CVCL_IR24	Cell lines
Derived from it	ISHIKAWA-Luc	CVCL_C9CC	Cell lines

1 to 10 of 31

See all 31 relatives

Cell banks5

Cell bank	Catalog number	Status	Source
BCRJ	0364		BCRJ
CLS	305262	Discontinued	Cellosaurus
ECACC	99040201		ECACC
EDITGENE	EDC00203		EDITGENE
Ubigene	YC-D023		Ubigene

Data dates

The date of each source this release read.

Cellosaurus: 2026-10-22; Cellosaurus
PubMed Central's articles: 2026-11-12; PubMed Central's articles
Our copy of PubMed: 2026-11-06; Our copy of PubMed

Sources 4

CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
PubMedNLM's terms

Each source's terms

CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
PubMedNLM's terms

Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.

For software

Read this cell line from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/cell-lines/v1/CVCL_2529

GET https://conductscience.org/api/cell-lines/v1/CVCL_2529/papers?page=2

API reference For AI assistants